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Editorial on the Research Topic
Optogenetics: An Emerging Approach in Cardiac Electrophysiology
Optogenetic techniques modulate excitable membranes through activation of photosensitive opsin
proteins functioning as light-gated channels, transporters or receptors. Of the known, prokaryotic,
algal or fungal, type I, and animal, type II, opsins, the type I opsins have been the most frequently
used experimentally since they were first to be expressed in mammalian neurons in the early 2000s.
Optogenetic approaches circumvent disadvantages of traditional, direct electrical stimulation,
methods, such as tissue toxicity, and enhance cellular and spatial specificity of stimulus effects
through genetic or developmental targeting.
These methods initially found neuroscience applications and these ranged widely from use
in in vitro models to behaving animals, and in invertebrate through to mammalian systems
(Boyden et al., 2005). They have more recently proved relevant to other excitable, particularly
cardiac, tissues, in the latter case, particularly in fundamental scientific and translational studies
of cardiac arrhythmogenesis (Bruegmann et al., 2016). Arrhythmias are the result of disruption of
the normally orderly electrical excitation sequence initiating co-ordinated and effective atrial or
ventricular contraction. They account for ∼3.7 million human deaths/year worldwide (Kuriachan
et al., 2017). Their clinical management has often lagged progress in many other cardiological
areas. This likely reflects our currently limited understanding of the physiological mechanisms that
underly their initiation, maintenance or propagation (Huang, 2017; Lei et al., 2018; Huang et al.,
2020).
Cardiac optogenetic approaches offer unprecedented opportunities and new exciting
possibilities to resolving and intervening in such normal and diseased function. Optogenetic
sensors can be incorporated into specific motifs and targeted at specific, tissue and cell types, and
subcellular domains, and applied at high spatial and temporal resolution. This Research Topic
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collects articles focusing on optogenetic applications in cardiac
electrophysiology. They particularly consider their ability to
modify membrane voltage, intracellular Ca2+ and cellular
signaling, and their potential for use in cardiac pacing,
cardioversion, cell communication, in arrhythmia research
(Boyle et al., 2018). Pioneering contributors in this cardiac field
summarize underlying concepts, existing optogenetic tools and
approaches, discussing their suitability for cardiac experimental
studies and interventions. They then review examples of
applications and situations where optogenetics have yielded new
insights into and potential interventional approaches for cardiac
physiology and cardiac disease.
Two background articles explore available optogenetic
approaches, opsin proteins and their different ion conductances,
kinetics, light sensitivity, and activation spectra, both in general,
and bearing on cardiac applications (Ferenczi et al.; O’Shea
et al.). These include the physical and practical background, and
choices of opsin tools appropriate to the cellular physiology and
experimental system in question (Deisseroth, 2015). Cardiac
expression of the chosen optogenetic tool is variously achieved
by coupling of “spark cells” at the single-cell level, construction of
transgenic mice or in vivo introduction of adenoviral expression
systems at the systems level. Adeno-associated viruses (AAVs)
offer advantages in long-term, cardiac-specific gene expression.
An article exploring optimal AAV serotypes (1, 6, or 9) reports
preferential efficiency of AAV1/6 in vitro and AAV9 in vivo
for cardiac optogenetic delivery (Ambrosi et al.). Optogenetic
stimulation either activates or silences cellular excitation through
membrane depolarization or hyperpolarization. Depolarizing,
activated, cation-conducting channelrhodopsins (ChR) trigger
cardiomyocyte action potentials; hyperpolarization by Cl−
pumps suppresses activity (Arrenberg et al., 2010). The
activated photosensitive Cl− channel, Guillardia theta ChR
(GtACR1) silences neuronal action potential generation:
microelectrode and in vivo optical whole heart recordings
demonstrate depolarized cells as expected from the cardiac
Cl− Nernst potential, inhibiting re-excitation (Kopton
et al.).
Optogenetic techniques promise to deliver unique
physiological insights unobtainable from established procedures.
At the cellular level, it could demonstrate, localize, and
characterize electrical and Ca2+ transient activity in particular
phenylethanolamine-N-methyl transferase (Pnmt)-derived
cardiomyocyte subpopulations and their roles in localized
adrenergic signaling (Fan et al.). At the whole heart level,
optogenetic methods permitted temporally precise, acute,
neuron-specific, parasympathetic stimulation in mice expressing
ChR2 in their peripheral cholinergic neurons. This elicited
sudden, dramatic but reversible heart rate reductions and
atrioventricular conduction delays (Moreno et al.).
Optogenetic techniques can target and stably deliver
perturbing light stimuli to specific cell types at the cellular, organ
or whole organism levels, in different cardiac, sino-atrial nodal,
atrial, ventricular regions, or the conducting tissues within or
between them, permitting focussed study of the entire range
of clinically important arrhythmic conditions. Thus, protocols
combining optogenetic stimulation with dual cytosolic Ca2+-
membrane voltage optical mapping studied membrane potential,
intracellular Ca2+ transients and pacemaker activity in a murine
sino-atrial preparation (Dong et al.). Use of pseudo two-
dimensional murine ventricular tissue slices profiled transmural
and regional voltage and Ca2+ signaling gradients under stress
produced by high frequency pacing, β-adrenergic stimulation or
pathological, including hypertrophic, conditions (He et al.). We
also include one report where the genetically-encoded sensor for
altered cellular glutathione redox status, Grx1-roGFP2, provided
readouts of cellular reactive oxygen species (Trautsch et al.).
The latter modulate ryanodine receptor-mediated sarcoplasmic
reticular Ca2+ release (Prosser et al., 2011) and phospholamban
phosphorylation-regulated diastolic relaxation (Scotcher et al.,
2016).
We complete the Research Topic by considering translational
exploitations of optogenetic methods in clinical cardiology. These
could achieve non-damaging optical control of excitation with
high temporal and spatial resolution for sino-atrial pacemaking,
or atrial or ventricular cardioversion. In contrast, normally
used electrical shocks do not fully control the spatial extent
and level of their resulting membrane potential changes. One
article summarizes recent progress on optogenetic defibrillation
and cardioversion, their underlying mechanisms and potential
patient populations that might thus benefit (Sasse et al.).
In channelrhodopsin-2 (ChR2) transgenic mice, a single 10–
1,000ms pulse at light intensities < 1.10 mW mm−2 sufficed
to cardiovert fibrillating hearts into sinus rhythm. Optical
mapping attributed this to both annihilating, excitation wave,
collisions and propagation perturbations (Quiñonez Uribe et al.).
Epicardial illumination terminated ventricular arrhythmias in
explanted, hypokalaemic hearts expressing the light-driven
proton pump ArchT, perfused with the KATP opener pinacidil.
This was accompanied by hyperpolarization, more rapid action
potential upstrokes but reduced conduction velocity implicating
an enhanced electrical sink in terminating the arrhythmia. Such
novel insights could improve our mechanistic understanding and
treatment strategies for arrhythmia termination (Funken et al.).
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